Naranjo, Antonio http://orcid.org/0000-0002-2013-6664
Molina, Amparo
Quevedo, Adrián
Rubiño, Francisco J.
Sánchez-Alonso, Fernando
Rodríguez-Lozano, Carlos
Ojeda, Soledad
Article History
Received: 1 November 2021
Accepted: 18 May 2022
First Online: 7 June 2022
Competing interests
: Naranjo A has received research grants from Amgen, consulting fees from UCB, and speaker bureau fees from Amgen and Lilly. Ojeda S has received research grants from Amgen and speaker bureau fees from Amgen and Lilly. Molina A has received speakers bureau fees from Amgen and Stada. The rest of the authors have no conflict of interest.